Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.64
Bid: 41.48
Ask: 41.54
Change: 0.74 (1.81%)
Spread: 0.06 (0.145%)
Open: 42.08
High: 42.08
Low: 41.20
Prev. Close: 40.90
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Jul 2019 07:00

RNS Number : 1070E
Assura PLC
02 July 2019
 

2 July 2019

Assura plc

 

Trading Update

For the first quarter to 30 June 2019

 

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

 

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of £17 million which was above book value.

 

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial £92 million.

 

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

 

"We remain confident in our outlook for the full year and in our longer-term prospects."

 

Developments and strategic acquisitions strengthen market-leading portfolio

· One development completed (Darley Dale) at a cost of £2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of £58 million.

· Two acquisitions completed in the period at a cost of £5.5 million.

· 12 disposals completed for £17 million cash consideration at a small premium to book value.

 

GPI acquisition expands pipeline

· Current portfolio of 554 properties.

· Immediate development pipeline of £77 million.

· Immediate acquisitions pipeline increased to £64 million, compared with £41 million at March 2019.

· Total immediate pipeline value, including on site developments, of £199 million up from £142 million at the year end.

 

Active portfolio management delivering value

· Six lease re-gears agreed on £0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

· Annualised rent roll at £102.1 million post disposals.

 

Strong financial position

· As at 30 June 2019 gross debt £730 million with undrawn facilities of £230 million plus cash balance of £47.5 million.

 

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFOOrla Ball, Company SecretaryDavid Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLRDEILIIA
Date   Source Headline
11th Jun 20215:24 pmRNSHolding(s) in Company
10th Jun 20213:03 pmRNSHolding(s) in Company
8th Jun 20214:27 pmRNSDirector/PDMR Shareholding
4th Jun 20217:00 amRNSAnnual Report & Notice of AGM
3rd Jun 20214:03 pmRNSHolding(s) in Company
3rd Jun 20218:38 amRNSDirector/PDMR Shareholding
3rd Jun 20217:00 amRNSNotice of Dividend
2nd Jun 20217:00 amRNSDevelopment update
27th May 20218:55 amRNSHolding(s) in Company
18th May 20211:03 pmRNSHolding(s) in Company
18th May 20217:00 amRNSAssura Full Year Results 2021
7th May 20211:24 pmRNSDirector/PDMR Shareholding
4th May 20218:08 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSTotal Voting Rights
22nd Apr 20217:00 amRNSNotice of Results
16th Apr 202110:01 amRNSDirector/PDMR Shareholding
12th Apr 20217:00 amRNSScrip Dividend Declaration
8th Apr 20217:00 amRNSAdditional Listing
7th Apr 20214:09 pmRNSDirector/PDMR Shareholding
6th Apr 20217:00 amRNSDirectorate Change
31st Mar 20218:47 amRNSHolding(s) in Company
25th Mar 20214:05 pmRNSHolding(s) in Company
22nd Mar 20217:50 amRNSHolding(s) in Company
18th Mar 202111:50 amRNSScrip Calculation Price
9th Mar 20212:16 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSInvestor Presentation
8th Mar 202110:05 amRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSNotice of Dividend
19th Feb 20217:00 amRNSAcquisition of Apollo
11th Feb 20214:25 pmRNSExercise of Nil Cost Options under PSP
11th Feb 20211:31 pmRNSHolding(s) in Company
8th Feb 20213:13 pmRNSDirector/PDMR Shareholding
5th Feb 20219:18 amRNSAdditional Listing
26th Jan 20213:47 pmRNSHolding(s) in Company
18th Jan 20213:57 pmRNSDirector/PDMR Shareholding
11th Jan 20217:00 amRNSScrip Dividend Declaration
11th Jan 20217:00 amRNSTrading Update
6th Jan 202112:18 pmRNSDirector/PDMR Shareholding
6th Jan 202110:03 amRNSDirector/PDMR Shareholding
17th Dec 20204:47 pmRNSScrip Calculation Price
16th Dec 20209:43 amRNSHolding(s) in Company
9th Dec 202010:42 amRNSDirector/PDMR Shareholding
8th Dec 20204:29 pmRNSHolding(s) in Company
3rd Dec 20207:00 amRNSNotice of Dividend
2nd Dec 20202:49 pmRNSHolding(s) in Company
1st Dec 20209:01 amRNSHolding(s) in Company
26th Nov 20203:23 pmRNSHolding(s) in Company
18th Nov 20205:33 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSInterim Results 2020
10th Nov 202011:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.